Related Experiment Video

Updated: May 8, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Cardiovascular disease in women: reducing cardiovascular comorbidity

Catinca Madrazo1

  • 1Ventura County Medical Center, 3291 Loma Vista Road, Ventura, CA 93003, USA. catinca.madrazo@gmail.com

FP Essentials
|August 28, 2013
PubMed

Insights

Cardiovascular disease is a major cause of death in women. Assessing risk using traditional factors and considering psychosocial elements can help reduce heart disease mortality.

Area of Science:

  • Cardiology
  • Public Health
  • Women's Health

Background:

  • Cardiovascular disease (CVD) is the primary cause of death among women globally.
  • The American Heart Association categorizes women's cardiovascular risk into ideal, at-risk, and high-risk levels.
  • Traditional risk factors include lipid levels, blood pressure, body mass index, and smoking status.

Purpose of the Study:

  • To review current guidelines for assessing cardiovascular risk in women.
  • To highlight the importance of incorporating psychosocial factors into risk assessment.
  • To emphasize a comprehensive approach for managing cardiovascular disease in women.

Main Methods:

  • Review of American Heart Association guidelines for cardiovascular risk assessment.
  • Inclusion of traditional cardiovascular risk factors (lipids, blood pressure, BMI, smoking).
  • Consideration of psychosocial factors such as marital status, depression, and anxiety.

Main Results:

  • The Framingham risk score is a tool to estimate 10-year risk of myocardial infarction or stroke.
  • Psychosocial disadvantages, marital status, depression, and anxiety are significant additional risk factors for women.
  • A multidisciplinary management strategy is recommended.

Conclusions:

  • Accurate cardiovascular risk stratification in women requires assessment of both traditional and psychosocial factors.
  • Integrating psychosocial stress management into care plans may reduce cardiovascular morbidity and mortality.
  • A holistic approach is crucial for improving cardiovascular health outcomes in women.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...